Tilt Biotherapeutics
TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor.
Total raised
€61M
€60,967,867
Funding rounds
4
Investors
6
distinct backers
Active since
2020-06
latest 2025-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood53
base rate 48% for Series B
- ▲ In typical raise window
- ▼ Low backer re-investment
Exit likelihood22
base rate 12% (2+ rounds)
- ▲ 4 rounds raised
- ▲ €30M+ raised
- ▲ 13y since founding
Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-13 | Series B | €23M | European Innovation Council (EIC) Fund,Finnish Industry Investment (Tesi),Lifeline Ventures,Stephen Industries | View deal → |
| 2023-02-07 | Other | €22M | Lifeline Ventures | View deal → |
| 2022-06-14 | Other | €10M | Lifeline Ventures,Tesi | View deal → |
| 2020-06-16 | Early VC | €6.2M | Business Finland | View deal → |
Investors
6Related news
- TILT Biotherapeutics Closes €22M Financing Roundfinsmes.com · 2023-02
- Tilt Biotherapeutics Raises $10.7M in Fundingfinsmes.com · 2022-06
- finsmes.com
- finsmes.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Iceye€1.5BFinland · Space
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Nokia€859MFinland · Telecom